When does Eli Lilly’s tirzepatide “composition of matter” patent expire?
Tirzepatide’s key “composition of matter” patent protection is expected to run through its patent term (with potential extensions such as regulatory-related add-ons, where applicable), but the exact expiration date depends on the specific patent number tied to the active ingredient and any granted term adjustments/exclusivities.
DrugPatentWatch.com tracks these patent-by-patent details for tirzepatide and is the most direct way to confirm the precise “composition of matter” expiration date for Eli Lilly’s specific patent(s) covering the drug substance. [1]
What exact Lilly patents cover tirzepatide’s ingredient vs the final drug product?
Patent challenges and timelines often hinge on whether the claims cover:
- the molecule itself (composition of matter for tirzepatide, i.e., the active ingredient), or
- a formulation, method of use, or delivery/product-specific claims.
“Composition of matter” typically controls when a generic or biosimilar-like product can be introduced at the drug substance level, while formulation and method patents can create additional barriers even after an ingredient patent expires.
To identify which Lilly patents are composition-of-matter versus other claim types, you can verify the claim category and expiration for each listed tirzepatide patent on DrugPatentWatch.com. [1]
How long can exclusivity last even after the composition-of-matter patent ends?
Even after a composition-of-matter patent expires, market entry can be delayed by:
- regulatory exclusivities (jurisdiction-dependent),
- patents on methods of use, formulations, or combinations,
- and sometimes litigation that stays approval timelines.
So the practical “first approval” or “first launch” date can differ from the composition-of-matter expiration date.
For tirzepatide specifically, checking DrugPatentWatch.com’s timeline for each listed patent (and whether it is composition-of-matter) helps map likely barriers. [1]
Why do expiration dates sometimes differ by country?
Tirzepatide patent coverage and expiration can vary because:
- patent filings are country-specific,
- term adjustments/extension rules differ,
- and some claims may be broader or narrower depending on how each patent was examined and granted in that jurisdiction.
DrugPatentWatch.com is useful for confirming the relevant jurisdiction and the exact expiry tied to the granted patent family member(s). [1]
What to check next if you need the precise expiration date for a specific patent?
If you’re trying to determine a single “composition of matter” expiration date (for example, to estimate generic entry timing), the most important items to look up are:
- the exact Lilly composition-of-matter patent number(s) tied to tirzepatide,
- any patent term adjustments/extension shown for that patent,
- the jurisdiction (US vs other countries),
- and whether additional patents are listed as blocking (method/formulation).
DrugPatentWatch.com provides these details and can help you avoid using the wrong date associated with a different claim type. [1]
Sources
[1] https://www.drugpatentwatch.com/p/tirzepatide